Keywords: Actelion, Financial results, Nine months 2012, Macitentan, Opsumit, Selexipag

Actelion post sales dip for first nine months, but back in profit

Article | 18 October 2012

Print This

Switzerland’s Actelion (SIX: ATLN) posted financial results for the first nine months of 2012, with product sales of 1.30 billion ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in